메뉴 건너뛰기




Volumn 53, Issue 1, 2014, Pages 86-94

Identification of metabolites of fosinopril produced by human and rat liver microsomes with liquid chromatography-mass spectrometry

Author keywords

Fosinopril; Fosinoprilat; Hydroxylated fosinopril metabolites; Metabolism; Q TOF MS; UHPLC

Indexed keywords

ANION; DRUG METABOLITE; FOSINOPRIL; FOSINOPRILAT; GLUCURONIDE;

EID: 84892720336     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.12.009     Document Type: Article
Times cited : (7)

References (12)
  • 1
    • 34250695963 scopus 로고    scopus 로고
    • Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma
    • 10.1016/j.jchromb.2007.04.019
    • S. Cui, F. Feng, M. Ma, H. Liu, and Y. Chen Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 854 2007 143 151 10.1016/j.jchromb.2007.04.019
    • (2007) J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. , vol.854 , pp. 143-151
    • Cui, S.1    Feng, F.2    Ma, M.3    Liu, H.4    Chen, Y.5
  • 2
    • 0019305428 scopus 로고
    • Analysis of intact glucuronides by mass spectrometry and gas chromatography-mass spectrometry. A review
    • C. Fenselau, and L.P. Johnson Analysis of intact glucuronides by mass spectrometry and gas chromatography-mass spectrometry. A review Drug Metab. Dispos. 8 1980 274 283
    • (1980) Drug Metab. Dispos. , vol.8 , pp. 274-283
    • Fenselau, C.1    Johnson, L.P.2
  • 3
    • 0028835364 scopus 로고
    • Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment
    • N.F. Ford, K.C. Lasseter, D.R.V. Harken, J.L. Hammett, R. Raymond, and J. Manning Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment J. Clin. Pharmacol. 35 1995 145 150
    • (1995) J. Clin. Pharmacol. , vol.35 , pp. 145-150
    • Ford, N.F.1    Lasseter, K.C.2    Harken, D.R.V.3    Hammett, J.L.4    Raymond, R.5    Manning, J.6
  • 4
    • 23044447454 scopus 로고    scopus 로고
    • Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent
    • 10.1016/j.chroma.2005.05.038
    • B. Jancic, D. Ivanovic, M. Medenica, A. Malenovic, and N. Dimkovic Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent J. Chromatogr. A 1088 2005 187 192 10.1016/j.chroma.2005.05.038
    • (2005) J. Chromatogr. A , vol.1088 , pp. 187-192
    • Jancic, B.1    Ivanovic, D.2    Medenica, M.3    Malenovic, A.4    Dimkovic, N.5
  • 5
    • 0022402388 scopus 로고
    • Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step derivatization
    • M. Jemal, E. Ivashkiv, M. Ribick, and A.I. Cohen Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step derivatization J. Chromatogr. B Biomed. Sci. Appl. 345 1985 299 307
    • (1985) J. Chromatogr. B Biomed. Sci. Appl. , vol.345 , pp. 299-307
    • Jemal, M.1    Ivashkiv, E.2    Ribick, M.3    Cohen, A.I.4
  • 6
    • 0034049782 scopus 로고    scopus 로고
    • Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation
    • 10.1002/1097-0231(20000630)14:12<1023::AID-RCM983>3.0.CO;2-K
    • M. Jemal, M. Huang, Y. Mao, D. Whigan, and A. Schuster Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation Rapid Commun. Mass Spectrom. 14 2000 1023 1028 10.1002/1097-0231(20000630)14:12<1023::AID-RCM983>3.0.CO;2-K
    • (2000) Rapid Commun. Mass Spectrom. , vol.14 , pp. 1023-1028
    • Jemal, M.1    Huang, M.2    Mao, Y.3    Whigan, D.4    Schuster, A.5
  • 7
    • 0027145520 scopus 로고
    • Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatocytes
    • M. Jurima-Romet, and H.S. Huang Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatocytes Biochem. Pharmacol. 46 1993 2163 2170
    • (1993) Biochem. Pharmacol. , vol.46 , pp. 2163-2170
    • Jurima-Romet, M.1    Huang, H.S.2
  • 8
    • 77958042850 scopus 로고    scopus 로고
    • Direct analysis of glucuronides with liquid chromatography-mass spectrometric techniques and methods
    • 10.2174/138920010792927343
    • R.A. Ketola, and K.S. Hakala Direct analysis of glucuronides with liquid chromatography-mass spectrometric techniques and methods Curr. Drug Metab. 11 2010 561 582 10.2174/138920010792927343
    • (2010) Curr. Drug Metab. , vol.11 , pp. 561-582
    • Ketola, R.A.1    Hakala, K.S.2
  • 9
    • 0030895678 scopus 로고    scopus 로고
    • Characterization of 1-hydroxypyrene as a novel marker substrate of 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase(s)
    • L. Luukkanen, E. Elovaara, P. Lautala, J. Taskinen, and H. Vainio Characterization of 1-hydroxypyrene as a novel marker substrate of 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase(s) Pharmacol. Toxicol. 80 1997 152 158
    • (1997) Pharmacol. Toxicol. , vol.80 , pp. 152-158
    • Luukkanen, L.1    Elovaara, E.2    Lautala, P.3    Taskinen, J.4    Vainio, H.5
  • 10
    • 0025240980 scopus 로고
    • Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs: In vivo and in vitro studies
    • R.A. Morrison, S.M. Singhvi, A.E. Peterson, D.A. Pocetti, and B.H. Migdalof Relative contribution of the gut, liver, and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs: in vivo and in vitro studies Drug Metab. Dispos. 18 1990 253 257
    • (1990) Drug Metab. Dispos. , vol.18 , pp. 253-257
    • Morrison, R.A.1    Singhvi, S.M.2    Peterson, A.E.3    Pocetti, D.A.4    Migdalof, B.H.5
  • 11
    • 0032470036 scopus 로고    scopus 로고
    • Fosinopril: Emerging considerations and implications for angiotensin-converting enzyme inhibitor therapy
    • D.A. Sica, T.W.B. Gehr, N. Kelleher, and M. Blumenthal Fosinopril: emerging considerations and implications for angiotensin-converting enzyme inhibitor therapy Cardiovasc. Drug Rev. 16 1998 319 345
    • (1998) Cardiovasc. Drug Rev. , vol.16 , pp. 319-345
    • Sica, D.A.1    Gehr, T.W.B.2    Kelleher, N.3    Blumenthal, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.